St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Erin Podolak, MA
Managing Editor
Erin Podolak, MA, is Managing Editor, Scientific Communication in the Strategic Communication Education and Outreach Department at St. Jude.
Stories by Erin Podolak
5 Questions for Lisett Contreras, PhD
Meet postdoctoral researcher Lisett Contreras, PhD, Department of Pathology, and learn about her research.
5 Questions for Anand Kulkarni, PhD
Learn what associate scientist Anand Kulkarni, PhD, thinks makes doing research at St. Jude different from anywhere else.
5 Questions for Janeala Morsby, PhD
Meet postdoctoral researcher Janeala Morsby, PhD, Department of Oncology and learn about her research.
5 Questions for Priyanka Dogra, PhD
Meet postdoctoral researcher Priyanka Dogra, PhD, Department of Structural Biology, and learn about her research.
5 Questions for Maowei Hu, PhD
Meet postdoctoral researcher Maowei Hu, PhD, Department of Chemical Biology & Therapeutics and learn about her research.
5 Questions for Cat Willis, PhD
In the Children’s GMP, LLC, Cat Willis, PhD, is the quality control “gatekeeper” making sure cell products are of the highest quality.
Like kisMET: targeted therapy and radiation synergize in pediatric high-grade glioma
Translational research from Suzanne Baker, PhD, and colleagues shows that targeted MET inhibitor capmatinib effectively crosses the blood-brain-barrier, synergizing with radiation to treat pediatric high-grade glioma.
Strength in numbers: Cooperative group clinical trials move the needle against pediatric cancer
Cooperative groups make it possible to more quickly and effectively study novel therapeutic approaches for treating pediatric cancers such as neuroblastoma through clinical trials.
Bone marrow transplantation for sickle cell disease improves myocardial fibrosis
St. Jude scientists have found for the first time that myocardial fibrosis caused by sickle cell disease can actually be improved by bone marrow transplantation.
5 Questions for Hongbo Chi, PhD
Learn about Hongbo Chi, PhD, St. Jude Department of Immunology.